In this webinar, we ask ‘Why have generative chemistry methods been unable to redefine modern drug discovery and compound idea generation?’ In this session we shed light on a typical shortcoming of generative methods.
Joe McDonald, Chief Data Officer at Odyssey Therapeutics, Peter Hunt, Director of Computational Chemistry at Optibrium Ltd and Ed Champness, CSO at Optibrium discuss experiences using generative methods and their ideas on how to close the gaps.
See how Optibrium’s Inspyra iteratively learns priorities for your projects, generating compound ideas tailored to your needs. Via your interactions, Inspyra guides generative chemistry and multi-parameter optimisation capabilities. It combines the explorative power of generative methods with your expert knowledge, helping you identify better compounds faster.
Other webinars you may be interested in
Mastering multi-parameter optimisation
Develop advanced MPO strategies and target the right compounds, faster.
We’re diving back into our favourite subject: multi-parameter optimisation.
Molecular docking: Extrapolating to new scaffolds with Surflex-Dock
Interested in improving your binding mode predictions? Surflex-Dock is a unique method for molecular docking, offering automatic pipelines for ensemble docking, applicable to both small molecules and large peptidic macrocycles alike.
